Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

Siang-Boon Koh; Yann Wallez; Charles R. Dunlop; Sandra Bernaldo de Quirós Fernández; Tashinga E. Bapiro; Frances M. Richards; Duncan I. Jodrell

doi:10.1158/0008-5472.CAN-17-3932

Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

Siang-Boon Koh^*
, Yann Wallez
, Charles R. Dunlop
, Sandra Bernaldo de Quirós Fernández
, Tashinga E. Bapiro
, Frances M. Richards
, Duncan I. Jodrell

^*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

35 Citations (Scopus)

Original language	Undefined/Unknown
Journal	Cancer Research
DOIs	https://doi.org/10.1158/0008-5472.CAN-17-3932
Publication status	Published - 1 Jun 2018

Access to Document

10.1158/0008-5472.CAN-17-3932

Handle.net

Persistent link

Cite this

@article{1ffcb386df314f87adb6b3740e0da05e,

title = "Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine",

author = "Siang-Boon Koh and Yann Wallez and Dunlop, \{Charles R.\} and Fern{\'a}ndez, \{Sandra Bernaldo de Quir{\'o}s\} and Bapiro, \{Tashinga E.\} and Richards, \{Frances M.\} and Jodrell, \{Duncan I.\}",

year = "2018",

month = jun,

day = "1",

doi = "10.1158/0008-5472.CAN-17-3932",

language = "Undefined/Unknown",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

AU - Koh, Siang-Boon

AU - Wallez, Yann

AU - Dunlop, Charles R.

AU - Fernández, Sandra Bernaldo de Quirós

AU - Bapiro, Tashinga E.

AU - Richards, Frances M.

AU - Jodrell, Duncan I.

PY - 2018/6/1

Y1 - 2018/6/1

UR - https://doi.org/10.1158/0008-5472.CAN-17-3932

U2 - 10.1158/0008-5472.CAN-17-3932

DO - 10.1158/0008-5472.CAN-17-3932

M3 - Article (Academic Journal)

C2 - 29735549

SN - 0008-5472

JO - Cancer Research

JF - Cancer Research

ER -

Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine

Access to Document

Handle.net

Other files and links

Cite this